|
Not yet recruiting
|
NCT05969821 -
Clonal Hematopoiesis of Immunological Significance
|
|
|
Not yet recruiting
|
NCT04702932 -
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
|
|
|
Active, not recruiting
|
NCT03327597 -
Iceland Screens, Treats or Prevents Multiple Myeloma
|
N/A |
|
Completed
|
NCT01588015 -
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
|
Phase 1 |
|
Completed
|
NCT04439006 -
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
|
Phase 1 |
|
Completed
|
NCT01955395 -
Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma
|
N/A |
|
Completed
|
NCT01219010 -
A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma
|
Phase 1 |
|
Completed
|
NCT01237054 -
Imaging in MGUS, SMM and MM
|
Phase 2 |
|
Recruiting
|
NCT05640843 -
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
|
N/A |
|
Completed
|
NCT00099047 -
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
|
Phase 2 |
|
Completed
|
NCT00919139 -
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
|
N/A |
|
Not yet recruiting
|
NCT05114109 -
Isatuximab in Type I Cryoglobulinemia
|
Phase 2 |
|
Recruiting
|
NCT04114084 -
Sleep Apnea in Patients With MGUS and MM
|
|
|
Recruiting
|
NCT06383143 -
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
|
|
|
Withdrawn
|
NCT01571726 -
Imaging Studies and the Development of Multiple Myeloma
|
Phase 2 |
|
Recruiting
|
NCT01408225 -
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
|
|
|
Recruiting
|
NCT05136807 -
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
|
|
|
Active, not recruiting
|
NCT04920084 -
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
|
N/A |
|
Recruiting
|
NCT06046287 -
Daratumumab for Polyneuropathy Associated With MGUS
|
Phase 2 |
|
Recruiting
|
NCT03119883 -
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
|
N/A |